Expert panel consensus recommendations on the use of circulating tumor <scp>DNA</scp> assays for patients with advanced solid tumors-Reference-Cited by-同舟云学术

Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumors

Published:2022-09-11 Issue:11 Volume:113 Page:3646-3656
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Imai Mitsuho¹²^ORCID,Nakamura Yoshiaki¹³^ORCID,Sunami Kuniko⁴^ORCID,Kage Hidenori⁵^ORCID,Komine Keigo⁶,Koyama Takafumi⁷^ORCID,Amano Toraji⁸,Ennishi Daisuke⁹,Kanai Masashi¹⁰^ORCID,Kenmotsu Hirotsugu¹¹^ORCID,Maeda Takahiro¹²,Morita Sachi¹³^ORCID,Sakai Daisuke¹⁴,Bando Hideaki¹³^ORCID,Makiyama Akitaka¹⁵,Suzuki Tatsuya¹⁶,Hirata Makoto¹⁷,Kohsaka Shinji¹⁸^ORCID,Tsuchihara Katsuya¹⁹^ORCID,Naito Yoichi²⁰^ORCID,Yoshino Takayuki¹³^ORCID

Affiliation:

1. Translational Research Support Section National Cancer Center Hospital East Kashiwa Japan

2. Genomics Unit Keio University School of Medicine Tokyo Japan

3. Department of Gastroenterology and Gastrointestinal Oncology National Cancer Center Hospital East Kashiwa Japan

4. Department of Laboratory Medicine National Cancer Center Hospital Tokyo Japan

5. Department of Next‐Generation Precision Medicine Development Laboratory Graduate School of Medicine The University of Tokyo Tokyo Japan

6. Department of Medical Oncology Tohoku University Hospital Sendai Japan

7. Department of Experimental Therapeutics National Cancer Center Hospital Tokyo Japan

8. Clinical Research and Medical Innovation Center Hokkaido University Hospital Hokkaido Japan

9. Center for Comprehensive Genomic Medicine Okayama University Hospital Okayama Japan

10. Department of Therapeutic Oncology Graduate School of Medicine Kyoto University Kyoto Japan

11. Division of Thoracic Oncology Shizuoka Cancer Center Suntougun Japan

12. Division of Precision Medicine Kyushu University Graduate School of Medical Sciences Fukuoka Japan

13. Department of Clinical Oncology and Chemotherapy Nagoya University Hospital Nagoya Japan

14. Center for Cancer Genomics and Personalized Medicine Osaka University Hospital Suita Japan

15. Cancer Center Gifu University Hospital Gifu Japan

16. Department of Hematology National Cancer Center Hospital Tokyo Japan

17. Department of Genetic Medicine and Services National Cancer Center Hospital Tokyo Japan

18. Division of Cellular Signaling National Cancer Center Research Institute Tokyo Japan

19. Division of Translational Informatics Exploratory Oncology Research and Clinical Trial Center National Cancer Center Kashiwa Japan

20. Department of General Internal Medicine/Experimental Therapeutics/Medical Oncology National Cancer Center Hospital East Kashiwa Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15504

Reference64 articles.

1. Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer

2. Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer

3. Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

4. Capturing Tumor Heterogeneity and Clonal Evolution by Circulating Tumor DNA Profiling

5. Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance;CA: A Cancer Journal for Clinicians;2024-01-04

2. Human resources for administrative work to carry out a comprehensive genomic profiling test in Japan;Cancer Science;2023-05-10

3. Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers;Cancer Research and Treatment;2023-04-15

4. Current Clinical Practice of Precision Medicine Using Comprehensive Genomic Profiling Tests in Biliary Tract Cancer in Japan;Current Oncology;2022-09-30